Radiotherapy of recurrent basal and squamous cell skin carcinomas: A study of 249 re-treated carcinomas in 229 patients

M. Caccialanza, R. Piccinno, A. Grammatica

Research output: Contribution to journalArticle

Abstract

It is of great practical utility to assess which is the best therapeutic choice in the management of basal and squamous cell skin carcinomas recurring after diferent treatments (RBSCSC). To this aim, we have performed a retrospective review of 249 recurrent lesions in 229 patients treated with dermatological radiotherapy in the period 1982-1999. The total doses of ionizing radiations administered ranged from 45 to 70 Gy, with different dose frationations, according to the technique employed. The five-year cure-rate was 83.62%. Cosmetic results were evaluated as "good" or "acceptable" in 92.62% of the treated lesions in complete remission. So far no complications or sequelae to the radiological treatment have been observed. Our results suggest two considerations about the choice in the treatment of RBSCSC (following non radiological therapies): 1. radiotherapy is a safe treatment and the most effective after Mohs surgery; 2. radiotherapy is a first-line treatment in those patients who cannot undergo extensive surgery for a variety of different reasons (age, general health conditions, etc.).

Original languageEnglish
Pages (from-to)25-28
Number of pages4
JournalEuropean Journal of Dermatology
Volume11
Issue number1
Publication statusPublished - 2001

Fingerprint

Squamous Cell Carcinoma
Radiotherapy
Carcinoma
Skin
Therapeutics
Mohs Surgery
Ionizing Radiation
Cosmetics
Health

Keywords

  • Basal cell skin carcinoma
  • Radio-therapy
  • Squamous cell skin carcinoma

ASJC Scopus subject areas

  • Dermatology

Cite this

Radiotherapy of recurrent basal and squamous cell skin carcinomas : A study of 249 re-treated carcinomas in 229 patients. / Caccialanza, M.; Piccinno, R.; Grammatica, A.

In: European Journal of Dermatology, Vol. 11, No. 1, 2001, p. 25-28.

Research output: Contribution to journalArticle

@article{080365bad4c14f1193a9f2edf18a1290,
title = "Radiotherapy of recurrent basal and squamous cell skin carcinomas: A study of 249 re-treated carcinomas in 229 patients",
abstract = "It is of great practical utility to assess which is the best therapeutic choice in the management of basal and squamous cell skin carcinomas recurring after diferent treatments (RBSCSC). To this aim, we have performed a retrospective review of 249 recurrent lesions in 229 patients treated with dermatological radiotherapy in the period 1982-1999. The total doses of ionizing radiations administered ranged from 45 to 70 Gy, with different dose frationations, according to the technique employed. The five-year cure-rate was 83.62{\%}. Cosmetic results were evaluated as {"}good{"} or {"}acceptable{"} in 92.62{\%} of the treated lesions in complete remission. So far no complications or sequelae to the radiological treatment have been observed. Our results suggest two considerations about the choice in the treatment of RBSCSC (following non radiological therapies): 1. radiotherapy is a safe treatment and the most effective after Mohs surgery; 2. radiotherapy is a first-line treatment in those patients who cannot undergo extensive surgery for a variety of different reasons (age, general health conditions, etc.).",
keywords = "Basal cell skin carcinoma, Radio-therapy, Squamous cell skin carcinoma",
author = "M. Caccialanza and R. Piccinno and A. Grammatica",
year = "2001",
language = "English",
volume = "11",
pages = "25--28",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "1",

}

TY - JOUR

T1 - Radiotherapy of recurrent basal and squamous cell skin carcinomas

T2 - A study of 249 re-treated carcinomas in 229 patients

AU - Caccialanza, M.

AU - Piccinno, R.

AU - Grammatica, A.

PY - 2001

Y1 - 2001

N2 - It is of great practical utility to assess which is the best therapeutic choice in the management of basal and squamous cell skin carcinomas recurring after diferent treatments (RBSCSC). To this aim, we have performed a retrospective review of 249 recurrent lesions in 229 patients treated with dermatological radiotherapy in the period 1982-1999. The total doses of ionizing radiations administered ranged from 45 to 70 Gy, with different dose frationations, according to the technique employed. The five-year cure-rate was 83.62%. Cosmetic results were evaluated as "good" or "acceptable" in 92.62% of the treated lesions in complete remission. So far no complications or sequelae to the radiological treatment have been observed. Our results suggest two considerations about the choice in the treatment of RBSCSC (following non radiological therapies): 1. radiotherapy is a safe treatment and the most effective after Mohs surgery; 2. radiotherapy is a first-line treatment in those patients who cannot undergo extensive surgery for a variety of different reasons (age, general health conditions, etc.).

AB - It is of great practical utility to assess which is the best therapeutic choice in the management of basal and squamous cell skin carcinomas recurring after diferent treatments (RBSCSC). To this aim, we have performed a retrospective review of 249 recurrent lesions in 229 patients treated with dermatological radiotherapy in the period 1982-1999. The total doses of ionizing radiations administered ranged from 45 to 70 Gy, with different dose frationations, according to the technique employed. The five-year cure-rate was 83.62%. Cosmetic results were evaluated as "good" or "acceptable" in 92.62% of the treated lesions in complete remission. So far no complications or sequelae to the radiological treatment have been observed. Our results suggest two considerations about the choice in the treatment of RBSCSC (following non radiological therapies): 1. radiotherapy is a safe treatment and the most effective after Mohs surgery; 2. radiotherapy is a first-line treatment in those patients who cannot undergo extensive surgery for a variety of different reasons (age, general health conditions, etc.).

KW - Basal cell skin carcinoma

KW - Radio-therapy

KW - Squamous cell skin carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035125488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035125488&partnerID=8YFLogxK

M3 - Article

C2 - 11174133

AN - SCOPUS:0035125488

VL - 11

SP - 25

EP - 28

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 1

ER -